Icatibant
Product Images NDC 72162-2106

Product Visual Gallery

This gallery contains 18 technical images submitted to the FDA as part of the official labeling for Icatibant (NDC 72162-2106). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

47c6a01-710b-46df-860c-c7938055b320 (Ica 01)

Chemical structure diagram of icatibant, showing its detailed molecular composition with peptide bonds and side chains.*

FDA Label Image

Edcd170-5080-4ca5-8519-ac5c5ecd1d96 (Ica 02)

A Kaplan-Meier plot showing the proportion of patients not achieving a 50% reduction in symptoms over time from dose (hours). The graph compares ICATIBANT INJECTION (N=43) versus placebo (N=45), with the ICATIBANT group showing a faster reduction in symptoms compared to placebo.*

FDA Label Image

D4e8da6-a3e4-4540-abef-f99fe01c7a91 (Ica 03)

An instructional diagram showing three labeled components: a prefilled syringe with a plunger, syringe barrel, and protective cap over the syringe tip; a capped needle with needle cap, needle, and needle cap seal; and an alcohol wipe packet labeled as not included in the carton.*

FDA Label Image

559f48a-7735-41be-aa9b-103a66c70a24 (Ica 04)

An instructional diagram showing how to open a box containing a syringe for ICATIBANT by Bryant Ranch Prepack. The illustration depicts a hand lifting the top flap of the box, revealing the syringe securely placed inside.*

FDA Label Image

E2731ae-6981-4dac-bd48-419909c23495 (Ica 05)

An instructional illustration showing a hand holding a vial or ampule being opened or a drop falling from it, and another hand positioned nearby presumably to receive the drop. The image likely depicts steps in drug administration or preparation.*

FDA Label Image

9a85091-5175-4678-855f-4adbd5c10ad8 (Ica 06)

An instructional diagram showing a hand holding a syringe with a detachable needle cap being pulled off, illustrating needle preparation for injection of ICATIBANT.*

FDA Label Image

901ca4b-3b1f-449f-8fd3-58d9f62559bc (Ica 07)

An instructional illustration showing hands holding a syringe with a needle cap being twisted or removed. The image visually demonstrates how to prepare the syringe for injection, likely for the administration of ICATIBANT.*

FDA Label Image

Fd99abd-70bb-41be-8fda-25a3ded73672 (Ica 08)

An illustration showing an abdomen with two shaded rectangular areas on either side, indicating injection or application sites for the product ICATIBANT. The image focuses on the front abdominal region.*

FDA Label Image

F8e6167-389e-46cc-9147-fcfe20c217e8 (Ica 09)

An illustration showing a person's hands positioned near their lower abdomen or pelvic area, depicting hand placement possibly related to medication administration or self-injection technique.*

FDA Label Image

Figure H (Ica 10)

An instructional illustration showing a hand holding a vial or medication container while another hand is depicted withdrawing liquid into a syringe. An arrow indicates the direction of the syringe needle inserting into the vial for filling.*

FDA Label Image

Figure I (Ica 11)

An instructional line drawing showing a hand holding a syringe with the thumb on the plunger, demonstrating how to hold the injection device before administration. No text or other markings are visible.*

FDA Label Image

Figure J (Ica 12)

A black and white line drawing illustrating the proper hand positioning for self-injection on the abdomen. The image shows a torso with a hand holding a syringe against the stomach area.*

FDA Label Image

Figure K (Ica 13)

An instructional diagram showing two hand positions for administering an injection at specific angles. The left image shows an injection held at a 45-degree angle to the skin, while the right image shows an injection held at a 90-degree angle to the skin. The illustrations highlight proper syringe positioning relative to the injection site on the arm or thigh.*

FDA Label Image

Figure L (Ica 14)

A black-and-white line drawing showing an injection being administered into a person's abdomen. The illustration depicts one hand holding a syringe while the other hand gently touches the injection site, demonstrating subcutaneous injection technique.*

FDA Label Image

Figure M (Ica 15)

Instructional diagram showing how to administer an injection into the outer thigh. One hand holds the syringe with needle pointing toward the thigh, and the other hand is positioned to stabilize the area for injection. An arrow indicates the direction of the injection.*

FDA Label Image

Figure N (Ica 16)

An instructional black-and-white line drawing showing a hand holding a syringe positioned near the side of a person's abdomen, indicating an injection site. An arrow points from the syringe to the abdomen, suggesting the direction of injection.*

FDA Label Image

Figure O (Ica 17)

An instructional illustration showing a hand holding a syringe vertically above an open biohazard sharps container labeled with a biohazard symbol and the warning 'DO NOT RECYCLE CONTAINS SHARPS,' with another hand unscrewing or holding the container cap to insert the syringe for disposal.*

FDA Label Image

Label (Lbl721622106)

Label for Icatibant Injection, 30 mg per 3 mL (10 mg/mL) in a single-dose, pre-filled syringe. The label includes storage instructions, usage warnings, and states the product contains no preservatives. It is relabeled by Bryant Ranch Prepack, Inc., and manufactured by Nang Kuang Pharmaceutical Co., Ltd. Barcodes and a QR code are also visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.